What Researchers Did
Researchers retrospectively compared conventional treatment alone versus conventional treatment combined with hyperbaric oxygen therapy in 28 patients with Fournier's gangrene.
What They Found
The mortality rate was lower in the HBOT group at 12.5% (2/16) compared to 33.3% (4/12) in the non-HBOT group. Additionally, the HBOT group experienced significantly fewer surgical debridements, shorter indwelling drainage tube times, and reduced curative times.
What This Means for Canadian Patients
If these findings are confirmed, adding hyperbaric oxygen therapy could potentially improve outcomes for Canadian patients with Fournier's gangrene. This might lead to fewer surgical procedures and faster recovery periods.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
This was a preliminary, single-center retrospective study with a small sample size, requiring larger multicenter studies for confirmation.